Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning
The FASEB Journal · 2023
DOI: 10.1096/fj.202201683r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Joseph Loscalzo. Beteiligte Einrichtung: Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Drug Repositioning, Drug Discovery. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, American Heart Association.
Abstract (Originalsprache)
Conventional drug discovery requires identifying a protein target believed to be important for disease mechanism and screening compounds for those that beneficially alter the target's function. While this approach has been an effective one for decades, recent data suggest that its continued success is limited largely owing to the highly prevalent irreducibility of biologically complex systems that govern disease phenotype to a single primary disease driver. Network medicine, a new discipline that applies network science and systems biology to the analysis of complex biological systems and disease, offers a novel approach to overcoming these limitations of conventional drug discovery. Using the comprehensive protein–protein interaction network (interactome) as the template through which subnetworks that govern specific diseases are identified, potential disease drivers are unveiled and the effect of novel or repurposed drugs, used alone or in combination, is studied. This approach to drug discovery offers new and exciting unbiased possibilities for advancing our knowledge of disease mechanisms and precision therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Joseph Loscalzo
Förderung
- American Heart Association-American Stroke Association
- NHLBI NIH HHS
- American Heart Association
Zitieren
APA
Loscalzo, J. (2023). Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning. The FASEB Journal. https://doi.org/10.1096/fj.202201683r
Vancouver
Loscalzo J. Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning. The FASEB Journal. 2023. doi:10.1096/fj.202201683r
BibTeX
@article{Loscalzo2023,
author = {Loscalzo, Joseph},
title = {Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202201683r}
}
EUVIMED